101 related articles for article (PubMed ID: 24164581)
1. Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
Qiao JX; Wang TC; Ruel R; Thibeault C; L'Heureux A; Schumacher WA; Spronk SA; Hiebert S; Bouthillier G; Lloyd J; Pi Z; Schnur DM; Abell LM; Hua J; Price LA; Liu E; Wu Q; Steinbacher TE; Bostwick JS; Chang M; Zheng J; Gao Q; Ma B; McDonnell PA; Huang CS; Rehfuss R; Wexler RR; Lam PY
J Med Chem; 2013 Nov; 56(22):9275-95. PubMed ID: 24164581
[TBL] [Abstract][Full Text] [Related]
2. Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent.
Jeon YT; Yang W; Qiao JX; Li L; Ruel R; Thibeault C; Hiebert S; Wang TC; Wang Y; Liu Y; Clark CG; Wong HS; Zhu J; Wu DR; Sun D; Chen BC; Mathur A; Chacko SA; Malley M; Chen XQ; Shen H; Huang CS; Schumacher WA; Bostwick JS; Stewart AB; Price LA; Hua J; Li D; Levesque PC; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2014 Mar; 24(5):1294-8. PubMed ID: 24513044
[TBL] [Abstract][Full Text] [Related]
3. Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility.
Wang TC; Qiao JX; Clark CG; Jua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Everlof G; Schumacher WA; Wong PC; Seiffert DA; Stewart AB; Bostwick JS; Crain EJ; Watson CA; Rehfuss R; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2013 Jun; 23(11):3239-43. PubMed ID: 23602442
[TBL] [Abstract][Full Text] [Related]
4. 4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution.
Qiao JX; Wang TC; Hiebert S; Hu CH; Schumacher WA; Spronk SA; Clark CG; Han Y; Hua J; Price LA; Shen H; Chacko SA; Everlof G; Bostwick JS; Steinbacher TE; Li YX; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
ChemMedChem; 2014 Oct; 9(10):2327-43. PubMed ID: 24989964
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists.
Chao H; Turdi H; Herpin TF; Roberge JY; Liu Y; Schnur DM; Poss MA; Rehfuss R; Hua J; Wu Q; Price LA; Abell LM; Schumacher WA; Bostwick JS; Steinbacher TE; Stewart AB; Ogletree ML; Huang CS; Chang M; Cacace AM; Arcuri MJ; Celani D; Wexler RR; Lawrence RM
J Med Chem; 2013 Feb; 56(4):1704-14. PubMed ID: 23368907
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
Yang W; Wang Y; Lai A; Qiao JX; Wang TC; Hua J; Price LA; Shen H; Chen XQ; Wong P; Crain E; Watson C; Huang CS; Seiffert DA; Rehfuss R; Wexler RR; Lam PY
J Med Chem; 2014 Jul; 57(14):6150-64. PubMed ID: 24931384
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
Peng J; Zhao L; Wang L; Chen H; Qiu Y; Wang J; Yang H; Liu J; Liu H
Eur J Med Chem; 2018 Oct; 158():302-310. PubMed ID: 30223118
[TBL] [Abstract][Full Text] [Related]
8. 2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.
Pi Z; Sutton J; Lloyd J; Hua J; Price L; Wu Q; Chang M; Zheng J; Rehfuss R; Huang CS; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2013 Jul; 23(14):4206-9. PubMed ID: 23743287
[TBL] [Abstract][Full Text] [Related]
9. 2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists.
Hu CH; Qiao JX; Han Y; Wang TC; Hua J; Price LA; Wu Q; Shen H; Huang CS; Rehfuss R; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2014 Jun; 24(11):2481-5. PubMed ID: 24767843
[TBL] [Abstract][Full Text] [Related]
10. Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y
Lei Y; Zhang B; Liu D; Zhao J; Dai X; Gao J; Mao Q; Feng Y; Zhao J; Lin F; Duan Y; Zhang Y; Bao Z; Yang Y; Mou Y; Wang S
J Med Chem; 2020 Dec; 63(24):15752-15772. PubMed ID: 33307675
[TBL] [Abstract][Full Text] [Related]
11. Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.
Thalji RK; Aiyar N; Davenport EA; Erhardt JA; Kallal LA; Morrow DM; Senadhi S; Burns-Kurtis CL; Marino JP
Bioorg Med Chem Lett; 2010 Jul; 20(14):4104-7. PubMed ID: 20542694
[TBL] [Abstract][Full Text] [Related]
12. New azole antagonists with high affinity for the P2Y(1) receptor.
Ruel R; L'Heureux A; Thibeault C; Daris JP; Martel A; Price LA; Wu Q; Hua J; Wexler RR; Rehfuss R; Lam PY
Bioorg Med Chem Lett; 2013 Jun; 23(12):3519-22. PubMed ID: 23668989
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel, potent, and orally active spiro-urea human glucagon receptor antagonists.
Shen DM; Zhang F; Brady EJ; Candelore MR; Dallas-Yang Q; Ding VD; Dragovic J; Feeney WP; Jiang G; McCann PE; Mock S; Qureshi SA; Saperstein R; Shen X; Tamvakopoulos C; Tong X; Tota LM; Wright MJ; Yang X; Zheng S; Chapman KT; Zhang BB; Tata JR; Parmee ER
Bioorg Med Chem Lett; 2005 Oct; 15(20):4564-9. PubMed ID: 16102966
[TBL] [Abstract][Full Text] [Related]
14. Studies towards the development of a PET radiotracer for imaging of the P2Y
Moldovan RP; Wenzel B; Teodoro R; Neumann W; Dukic-Stefanovic S; Kraus W; Rong P; Deuther-Conrad W; Hey-Hawkins E; Krügel U; Brust P
Eur J Med Chem; 2019 Mar; 165():142-159. PubMed ID: 30665144
[TBL] [Abstract][Full Text] [Related]
15. Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.
Ruel R; L'Heureux A; Thibeault C; Lapointe P; Martel A; Qiao JX; Hua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Wexler RR; Rehfuss R; Lam PY
Bioorg Med Chem Lett; 2013 Dec; 23(24):6825-8. PubMed ID: 24269480
[TBL] [Abstract][Full Text] [Related]
16. Two disparate ligand-binding sites in the human P2Y1 receptor.
Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
[TBL] [Abstract][Full Text] [Related]
17. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
[TBL] [Abstract][Full Text] [Related]
18. Optimization of P2Y
Kong D; Xue T; Guo B; Cheng J; Liu S; Wei J; Lu Z; Liu H; Gong G; Lan T; Hu W; Yang Y
J Med Chem; 2019 Mar; 62(6):3088-3106. PubMed ID: 30843696
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y
Liu X; Gao ZG; Wu Y; Stevens RC; Jacobson KA; Zhao S
Sci Rep; 2018 May; 8(1):8084. PubMed ID: 29795391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
